Glucose Variability and β- Cell Response by GLP-1 Analogue added-on CSII for Patients with Poorly Controlled Type 2 Diabetes. [electronic resource]
Producer: 20160926Description: 16968 p. digitalISSN:- 2045-2322
- Adiponectin -- metabolism
- Biomarkers -- metabolism
- Blood Glucose -- metabolism
- C-Peptide -- metabolism
- Cardiovascular Diseases -- complications
- Diabetes Mellitus, Type 2 -- blood
- Endpoint Determination
- Exenatide
- Female
- Glucagon-Like Peptide 1 -- agonists
- Glucose Tolerance Test
- Humans
- Injections, Subcutaneous
- Insulin -- administration & dosage
- Insulin Infusion Systems
- Insulin Resistance
- Insulin-Secreting Cells -- drug effects
- Male
- Middle Aged
- Peptides -- pharmacology
- Risk Factors
- Venoms -- pharmacology
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.